Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Neonatal Sepsis

vancomycin has been researched along with Neonatal Sepsis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (46.15)24.3611
2020's7 (53.85)2.80

Authors

AuthorsStudies
Bjørnholt, JV; Rønnestad, A; Solevåg, AL; Stensvold, HJ; Størdal, EH1
Hanson, S; Laible, B; Nazir, J; Nelson, G; Preszler, M; Siewert, A1
Butin, M; Callies, A; Crémet, L; Flamant, C; Gély, L; Gregoire, M; Guillouzouic, A; Launay, E; Martin-Perceval, L; Prot-Labarthe, S; Ruellan, AL; Verdier, MC1
Ding, L; Ding, X; Duan, L; Liu, C; Mao, J; Shi, L; Sun, J; Tang, L; Wang, W; Wu, D; Xie, L; Xu, J; Yang, Z; Zhou, Q1
Hardy, P; Heath, PT; Hill, LF; Jacqz-Aigrain, E; Linsell, L; Lutsar, I; Roilides, E; Sharland, M; Turner, MA1
Barbier, M; Bergot, M; Butin, M; Jacob, L; Kearns, A; Laurent, F; Martins-Simoes, P; Picaud, JC; Pichon, B; Pike, R; Rasigade, JP; Supply, P; Tissieres, P; Wirth, T1
Greisen, G; Gupta, M; Jakobsen, JC; Korang, SK; Lausten-Thomsen, U; Nava, C; Safi, S1
Astorga, MC; Ebert, AM; Ebert, SC; Kling, PJ; Menda, N; Piscitello, KJ; Porte, MA1
Cranswick, N; Curtis, N; Donath, SM; Gwee, A; Hunt, R1
Amberpet, R; Bairy, I; Chaudhary, D; Gokhale, S; Nayak, N; Padukone, S; Subramanya, SH1
Docobo-Pérez, F; Felton, TW; Goodwin, J; Hope, WW; Jacqz-Aigrain, E; Johnson, A; Livermore, J; McEntee, L; Ramos-Martín, V; Sharland, M; Turner, MA; Whalley, S; Zhao, W1
Fang, J; Li, JJ; Shang, EN; Tang, L; Wang, SN; Weng, XH1
Aho, V; Andersson, S; Auvinen, P; Lauerma, A; Lybeck, E; Nupponen, I; Paulin, L; Pereira, P; Ranki, A; Salava, A1

Reviews

1 review(s) available for vancomycin and Neonatal Sepsis

ArticleYear
Antibiotic regimens for late-onset neonatal sepsis.
    The Cochrane database of systematic reviews, 2021, 05-08, Volume: 5

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bias; Cefazolin; Clavulanic Acid; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Randomized Controlled Trials as Topic; Ticarcillin; Vancomycin

2021

Trials

2 trial(s) available for vancomycin and Neonatal Sepsis

ArticleYear
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled tria
    Trials, 2020, Apr-15, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Clinical Protocols; Dose-Response Relationship, Drug; Equivalence Trials as Topic; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Safety; Staphylococcal Infections; Vancomycin

2020
Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
    BMJ open, 2018, 11-03, Volume: 8, Issue:11

    Topics: Anti-Bacterial Agents; Drug Monitoring; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Neonatal Sepsis; Vancomycin

2018

Other Studies

10 other study(ies) available for vancomycin and Neonatal Sepsis

ArticleYear
Sepsis treatment options identified by 10-year study of microbial isolates and antibiotic susceptibility in a level-four neonatal intensive care unit.
    Acta paediatrica (Oslo, Norway : 1992), 2022, Volume: 111, Issue:3

    Topics: Anti-Bacterial Agents; Gentamicins; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Sepsis; Vancomycin

2022
Antibiotic Prescribing Practices in Group B Streptococcus Positive Obstetric Patients with Penicillin Allergy.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2022, Volume: 75, Issue:10

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clindamycin; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Infant, Newborn; Neonatal Sepsis; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae; Vancomycin

2022
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.
    The Pediatric infectious disease journal, 2023, 10-01, Volume: 42, Issue:10

    Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Sepsis; Staphylococcal Infections; Vancomycin

2023
A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China.
    BMC health services research, 2023, Jul-19, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; China; Coagulase; Cost-Effectiveness Analysis; Drug Costs; Female; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Neonatal Sepsis; Retrospective Studies; Treatment Outcome; Vancomycin

2023
Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
    Nature microbiology, 2020, Volume: 5, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bayes Theorem; Drug Resistance, Multiple, Bacterial; France; Genes, Bacterial; Genome-Wide Association Study; Genome, Bacterial; Genotype; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Mutation; Neonatal Sepsis; Phenotype; Polymorphism, Single Nucleotide; Recombination, Genetic; Staphylococcal Infections; Staphylococcus capitis; Vancomycin

2020
Antibiotic Stewardship in the Neonatal Intensive Care Unit: Effects of an Automatic 48-Hour Antibiotic Stop Order on Antibiotic Use.
    Journal of the Pediatric Infectious Diseases Society, 2019, Sep-25, Volume: 8, Issue:4

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Drug Utilization; Drug Utilization Review; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Neonatal Sepsis; Retrospective Studies; Vancomycin

2019
Neonatal sepsis due to glycopeptide resistant
    Antimicrobial resistance and infection control, 2019, Volume: 8

    Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Feces; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Linezolid; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Vancomycin; Vancomycin Resistance

2019
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Algorithms; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Models, Theoretical; Monte Carlo Method; Neonatal Sepsis; Rabbits; Staphylococcal Infections; Staphylococcus; Vancomycin

2016
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2016, Volume: 54, Issue:9

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Infant, Newborn; Linezolid; Male; Middle Aged; Neonatal Sepsis; Oxazolidinones; Platelet Count; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin

2016
Loss of cutaneous microbial diversity during first 3 weeks of life in very low birthweight infants.
    Experimental dermatology, 2017, Volume: 26, Issue:10

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Humans; Incubators, Infant; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Microbiota; Neonatal Sepsis; Netilmicin; Penicillin G; Skin; Staphylococcus; Time Factors; Vancomycin

2017